Zum Hauptinhalt springen
Phesgo (Pertuzumab / Trastuzumab) 600 mg – Targeted Therapy for HER2-Positive Breast Cancer  Phesgo (Pertuzumab/Trastuzumab) - Macrocare Health Blog

Phesgo (Pertuzumab / Trastuzumab) 600 mg – Targeted Therapy for HER2-Positive Breast Cancer Phesgo (Pertuzumab/Trastuzumab)

Phesgo (Pertuzumab/Trastuzumab) Phesgo (Pertuzumab / Trastuzumab) is a targeted biologic therapy used in the treatment of HER2-positive breast cancer. It helps slow cancer cell growth and improve treatment outcomes.

 

What is Phesgo?

Phesgo combines two targeted therapies:

  • Pertuzumab
  • Trastuzumab

The medication works by targeting the HER2 protein, which is overexpressed on the surface of certain breast cancer cells.

It helps to:

  • Slow the growth of cancer cells
  • Prevent tumor progression and spread
  • Enhance treatment effectiveness when used with chemotherapy or other therapies

In simple terms:
It is a targeted treatment that blocks the HER2 receptor responsible for the growth of certain breast cancers.

 

Indications

Phesgo (Pertuzumab / Trastuzumab) is used in:

  • Early-stage HER2-positive breast cancer
  • Advanced or metastatic HER2-positive breast cancer
  • Treatment protocols before or after surgery
  • Combination regimens with other cancer therapies as prescribed

 

Dosage and Administration

  • Dose: 600 mg according to the treatment protocol
  • Administered as a subcutaneous injection
  • Given by a specialized healthcare team
  • Treatment schedule varies depending on the prescribed regimen

 

Common Side Effects

May include:

  • Fatigue
  • Nausea or diarrhea
  • Hair loss when combined with chemotherapy
  • Injection site reactions
  • Low blood cell counts

Rarely: heart-related side effects requiring regular monitoring.

 

Monitoring During Treatment

Patients on Phesgo require:

  • Cardiac function monitoring
  • Assessment of tumor response
  • Complete blood count (CBC) monitoring
  • Evaluation of overall patient condition

 

Availability & How to Access Treatment

Phesgo (Pertuzumab/Trastuzumab) is available through Macrocare’s approved partners.

You can now request and access the medication easily through us.

WhatsApp contact for medication requests:
Click here

 

Phesgo (Pertuzumab/Trastuzumab) Phesgo (Pertuzumab / Trastuzumab) 600 mg is a targeted biologic therapy for HER2-positive breast cancer that works by blocking HER2 receptors and improving disease control.

 

Medical Disclaimer:
This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.

Weitere Artikel

Handynummer eingeben

Bitte teilen Sie uns Ihre Telefonnummer mit, damit wir Sie zu Ihrem gesundheitlichen Anliegen kontaktieren können.

Datenschutz gewährleistet: Ihre medizinischen und persönlichen Informationen werden streng vertraulich behandelt und mit branchenüblichen Schutzstandards gesichert.

KONTAKT AUFNEHMEN

Kontakt

Bitte teilen Sie uns Ihre Telefonnummer mit, damit wir Sie zu Ihrem gesundheitlichen Anliegen kontaktieren können.